The higher CRP prevalence (41%) may be explained by the high prevalence of overweight and obesity in our study population, as CRP (an inflammatory marker) is often increased in persons with increased central obesity [6]. This evidence concerns the gene CRP and obesity due to melanocortin 4 receptor deficiency.